Chì significà "Clear"?
L'animali ùn porta micca a mutazione. Ùn svilupperà micca a malatia è ùn la trasmetterà.
Cane Acromatopsia di tipo 3 in puntatore tedesco a pelo corto (PRAcd)
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers is essential for responsible breeding. This genetic screening identifies carriers of the PRAcd mutation, which causes progressive vision loss and color blindness in affected dogs. Early detection through DNA testing helps breeders prevent passing this hereditary condition to future generations. By using the PRAcd test, owners can ensure healthier litters and maintain the breed’s overall well-being. Regular testing supports informed breeding decisions and promotes the longevity of German Shorthaired Pointers. Protect your dog’s vision and contribute to breed health with the Achromatopsia Type 3 DNA test.
Abbreviazione: PRAcd
mutazione analizzata: CNGB3 c.784G>A
Eredità : Autosomal Recessive
Acronimu
PRAcd
Frequenza osservata
Gravità clinica
Classificazione clinica
Malatie oftalmiche
Mutazione analizata
CNGB3 c.784G>A
p.(D262N)
p.(D262N)
Modu di l'eredi
Autosomal Recessive
Riassuntu di a prova:
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers helps identify carriers and affected dogs. This inherited condition causes complete color blindness and vision problems. Early testing allows breeders to make informed decisions to reduce the risk of passing the disorder. By screening breeding dogs, the prevalence of PRAcd can be minimized in future generations. Responsible breeding ensures healthier dogs with better quality of life.
Disponibile da u pacchettu: Basic
Questa prova di DNA hè inclusa partendu da u nostru pacchettu Basic — è hè ancu parte di i pacchetti Basic, Standard, Advanced, Complete.
Vede i pacchetti di test di DNA →Sceglite u pacchettu chì si adatta megliu à a vostra strategia di allevamentu o di salute di i vostri animali.
Understanding Achromatopsia Type 3 in German Shorthaired Pointers
Achromatopsia Type 3, also known as Progressive Retinal Atrophy with complete color blindness (PRAcd), is a hereditary condition that affects the vision of German Shorthaired Pointers. This genetic disorder results from mutations in specific genes that are crucial for the proper functioning of photoreceptor cells in the retina, leading to vision impairment over time.
Symptoms of Achromatopsia Type 3
Dogs affected by Achromatopsia Type 3 typically exhibit symptoms such as a lack of color vision, difficulty seeing in bright light, and potential night blindness. Owners may notice that their dogs have trouble navigating their environment, particularly in brightly lit areas, as their ability to perceive colors is significantly diminished.
Genetic Basis of the Condition
This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the dog to express the disease. Carriers, which have one normal and one mutated gene, do not show symptoms but can pass the condition to their offspring. Identifying carriers through DNA testing is essential for responsible breeding practices, as it helps prevent the propagation of the condition in future generations.
Impattu nantu à a qualità di vita
While Achromatopsia Type 3 can lead to significant visual impairment, many dogs adapt well to their condition. Owners can assist by providing a safe environment and ensuring that their pets are comfortable in low-light conditions or areas with bright lighting. Understanding the limitations of their dog's vision allows owners to make necessary adjustments to enhance their pet's quality of life.
Gestione è Cura
Managing a dog with Achromatopsia Type 3 primarily involves environmental modifications rather than medical interventions. Owners should ensure that their living space is free from obstacles that could pose a danger, as affected dogs may not respond to visual cues in the same way as their sighted counterparts. Regular veterinary check-ups are also advised to monitor the dog's overall eye health and address any other potential issues that may arise.
Cunclusioni
Achromatopsia Type 3 in German Shorthaired Pointers is a serious genetic condition that affects visual perception. Understanding the symptoms, genetic basis, and management strategies is crucial for owners and breeders alike. Through responsible breeding and proper care, the impact of this condition on affected dogs can be alleviated, allowing them to lead fulfilling lives despite their visual challenges.
Razza ricunnisciuta per a prova : Acromatopsia di tipo 3 in puntatore tedesco a pelo corto (PRAcd)
- German Shorthaired Pointer
🧬 Interpretation of genotypes PRAcd
Genotipu
Status
🟡 N/N
Non trasportatore - Nisun Riscu
🟡 N/PRAcd
Carrier - Nisun Riscu
❌ PRAcd/PRAcd
Affettatu - À Risicu
FAQ: capiscenu l'interpretazione
Hè un "Carrier" seriu?
No. L'animali hè generalmente sanu, ma pò trasmette a mutazione à u so prole.
E se un animale hè "Affettatu"?
Porta duie copie mutate. I segni clinichi sò previsti secondu a malatia. Ùn deve esse criatu.
Perchè ci sò differenze trà maschile / femina?
Alcune malatie sò ligati à u sessu, cusì a so espressione varieghja secondu u sessu di l'animali.
Prevede a prole
N/N (non-traspurtadore)
N/PRAcd (Carrier)
PRAcd/PRAcd (Affettatu)
FAQ Test di DNA
Chì rileva stu test di DNA?
This DNA test detects the mutation associated with Achromatopsia Type 3 In German Shorthaired Pointer (PRAcd) in order to identify clear, carrier, or at-risk animals.
Perchè pruvà un animale di ripruduzzione?
A prova di DNA aiuta i criatori à pianificà accoppiamenti più sicuri è riduce u risicu di trasmette a mutazione à a prole.
Chì ghjè u modu di eredità di sta prova?
U modu di eredità rappurtatu per questa prova hè Autosomal Recessive.
Quale mutazione hè analizata in questa prova?
This test analyses the mutation CNGB3 c.784G>A.
Hè un animale trasportatore necessariamente affettatu?
Micca necessariamente. L'interpretazione dipende da u mudellu di eredità è u genotipu resultanti.
Referenze
Sidjanin Duska J, Lowe Jennifer K, McElwee John L, Milne Bruce S, Phippen Taryn M, Sargan David R, Aguirre Gustavo D, Acland Gregory M, Ostrander Elaine A. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002 Aug 1;11(16):1823-33. doi: 10.1093/hmg/11.16.1823.